Fingerprint
Dive into the research topics of 'Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma
Filipe V. Almeida, Stephen M. Douglass, Mitchell E. Fane, Ashani T. Weeraratna
Research output: Contribution to journal › Review article › peer-review
16
Scopus
citations